Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.26 USD | -0.27% | -0.32% | +25.35% |
06-27 | Barclays Adjusts Catalent Price Target to $63 From $47 | MT |
06-24 | Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.35% | 10.21B | |
+56.75% | 819B | |
-6.57% | 351B | |
+19.18% | 329B | |
+9.37% | 298B | |
+16.74% | 242B | |
+2.17% | 225B | |
+13.17% | 217B | |
+8.91% | 168B | |
-3.00% | 158B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Catalent, Novo Nordisk Antitrust Review Extended by FTC